A recent study demonstrated that the BRAF mutation significantly enhances cytotoxic T cell infiltration in the tumor microenvironment of colorectal cancer, indicating its potential as a favorable factor for immunotherapy [32]. This evidence concerns the gene BRAF and colorectal cancer.